321 related articles for article (PubMed ID: 10363178)
1. Tissue levels of chemotherapeutic agents for hepatic metastasis during hepatic arterial and portal injection.
Kaneko A; Naomoto Y; Aoyama M; Tanaka N
In Vivo; 1999; 13(2):195-8. PubMed ID: 10363178
[TBL] [Abstract][Full Text] [Related]
2. [In vivo comparative study of the pharmacokinetics of chemotherapeutic agents infused via hepatic artery or portal vein against hepatic metastases. DRC Group].
Naomoto Y; Gochi A; Hizuta A; Iwagaki H; Matsuno T; Hamazaki K; Tanaka N; Orita K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1555-8. PubMed ID: 8373217
[TBL] [Abstract][Full Text] [Related]
3. [Hepatic artery and portal vein infusion of adriamycin in experimental liver metastasis].
Kuroda K; Horita Y; Sakane M; Okumoto S; Katoh M; Saitoh Y
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2859-62. PubMed ID: 2782893
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study on the comparative efficacy of hepatic arterial or portal venous infusion of adriamycin to control hepatic carcinoma growth].
Hoshino M; Koyama Y; Abe R
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1894-7. PubMed ID: 1877833
[TBL] [Abstract][Full Text] [Related]
5. Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion.
Ridge JA; Collin C; Bading JR; Hancock C; Conti PS; Daly JM; Raaf JH
Cancer Res; 1988 Aug; 48(16):4584-7. PubMed ID: 3396009
[TBL] [Abstract][Full Text] [Related]
6. [Experimental studies on drug uptake by metastatic liver tumor after intra-arterial, intraportal and intravenous administration of BrdU].
Shioaki Y; Taniguchi H; Itoh A; Daidoh T; Seiki K; Yamaguchi T; Sawai K; Takahashi T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2829-32. PubMed ID: 2782892
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study on comparative efficacy of hepatic arterial injection of anticancer agent under temporary occlusion of portal vein].
Shirosaki I; Tazawa K; Kushibuchi T; Okamoto M; Yamagishi F; Bandou T; Shimoda M; Takemori S; Suzuki S; Yamashita Y
Gan To Kagaku Ryoho; 1993 May; 20(7):937-9. PubMed ID: 8489299
[TBL] [Abstract][Full Text] [Related]
8. Anticancer effects of local administration of mitomycin C via the hepatic artery or portal vein on implantation and growth of VX2 cancer injected into rabbit liver.
Izumi B; Tashiro S; Miyauchi Y
Cancer Res; 1986 Aug; 46(8):4167-70. PubMed ID: 3089588
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of 5-FU + leucovorin therapy by continuous arterial infusion].
Mori T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2838-41. PubMed ID: 2789495
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of the efficacy of hepatic arterial and portal venous infusion of adriamycin for prevention of liver metastases in rabbit VX2].
Koyama Y; Hoshino M; Igarashi W; Ono T; Hatakeyama Y; Abe R
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1540-3. PubMed ID: 1530303
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
Zheng JL; Liang LJ; Hu WJ; Shen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
[TBL] [Abstract][Full Text] [Related]
12. Establishment of an experimental model for continuous intraportal infusion of chemo/immunotherapeutic agents in the rat.
Rafique M; Adachi W; Shiohara E
Anticancer Res; 1995; 15(5B):1869-72. PubMed ID: 8572571
[TBL] [Abstract][Full Text] [Related]
13. [An experimental study on portal infusion of 5-fluorouracil (the second report)].
Ishida H; Iwama T; Ide A; Nihei Z; Imajo M; Mishima Y
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1532-5. PubMed ID: 1530301
[TBL] [Abstract][Full Text] [Related]
14. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.
Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G
Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343
[TBL] [Abstract][Full Text] [Related]
15. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL
Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic studies of continuous and bolus intraportal 5-fluorouracil infusion].
Hanai A; Yamamura T; Matsuzaki H; Oikawa H; Kikuchi K; Ozasa T; Akaishi O; Senda T; Katayama K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1536-9. PubMed ID: 1530302
[TBL] [Abstract][Full Text] [Related]
17. Epirubicin and its metabolites levels in experimental liver metastases after different administration routes.
Bacchetti S; Pasqual E; Cagol PP
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):181-5. PubMed ID: 16767928
[TBL] [Abstract][Full Text] [Related]
18. [Enhanced effect of hepatic arterial infusion of anticancer drugs of rabbit VX-2 hepatic implants].
Koyama Y; Hoshino M; Ono T; Inoue N; Tsuchiya A; Abe R
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1721-4. PubMed ID: 2167643
[TBL] [Abstract][Full Text] [Related]
19. Concentration change of chemotherapeutic agents in plasma and tissue after intraarterial and intravenous injection.
Zhang Y; Ge Y; Cai S; Lu G
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):344-7. PubMed ID: 12408760
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic studies on continuous intraportal 5-fluorouracil infusion].
Matsuzaki H; Yamamura T; Hanai A; Oikawa H; Kikuchi K; Seo K; Ozasa T; Akaishi O; Tsukikawa S; Yamaguchi S
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2121-3. PubMed ID: 7944418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
